Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes

Eur J Immunol. 1998 Feb;28(2):496-501. doi: 10.1002/(SICI)1521-4141(199802)28:02<496::AID-IMMU496>3.0.CO;2-V.

Abstract

PTX3 is a prototypic long pentraxin expressed by various cell types, most prominently monocytes and endothelial cells, in response to interleukin-1 (IL-1), tumor necrosis factor (TNF) and bacterial products. In the present report, we show that interferon-gamma (IFN-gamma) inhibits the expression of the PTX3 gene induced by exposure to IL-1, TNF or lipopolysaccharide in human monocytes. This effect is dose dependent and observable when IFN-gamma is added from 24 h before up to 3 h after the addition of IL-1. While the time course of the IL-1-induced PTX3 mRNA expression is not affected, IFN-gamma reduces the stability of the PTX3 mRNA as well as its transcription. The inhibition of PTX3 expression is restricted to monocytes in that no inhibition occurs in cytokine-stimulated fibroblasts and endothelial cells. Under the same conditions, as expected, IFN-gamma augmented monocyte chemotactic protein-1 expression in the same cell preparations. PTX3 protein secretion by activated monocytes is also suppressed by exposure to IFN-gamma. Altogether, these data identify a negative pathway of regulation mediated by IFN-gamma, which may occur under inflammatory conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • C-Reactive Protein / antagonists & inhibitors*
  • C-Reactive Protein / biosynthesis*
  • C-Reactive Protein / genetics
  • Cell Line
  • Cells, Cultured
  • Chemokine CCL2 / antagonists & inhibitors
  • Chemokine CCL2 / biosynthesis
  • Half-Life
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Interferon-gamma / pharmacology*
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • RNA, Messenger / antagonists & inhibitors
  • Serum Amyloid P-Component / antagonists & inhibitors*
  • Serum Amyloid P-Component / biosynthesis*
  • Serum Amyloid P-Component / genetics
  • Time Factors
  • Transcription, Genetic / drug effects

Substances

  • Chemokine CCL2
  • Immunosuppressive Agents
  • RNA, Messenger
  • Serum Amyloid P-Component
  • PTX3 protein
  • Interferon-gamma
  • C-Reactive Protein